Back
Intellia Therapeutics Vs. Navidea Biopharmaceuticals Industry Stock Comparison
Sell
23
NTLA
Intellia Therapeutics
Last Price:
21.86
Seasonality Move:
34.64%
Sell
32
NAVB
Navidea Biopharmaceuticals
Last Price:
0.03
Seasonality Move:
6.85%
Sell
23
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.92. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Navidea Biopharmaceuticals (NAVB)
is a Sell
Is Navidea Biopharmaceuticals a Buy, Sell or Hold?
- The current Navidea Biopharmaceuticals [NAVB] share price is $0.04. The Score for NAVB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- NAVB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.
NAVB Stock Price Chart
What is Navidea Biopharmaceuticals's stock price today?
-
The Navidea Biopharmaceuticals share price today is $0.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAVB is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.08 | Sell |
Relative Strength Index (14 RSI): | 31.44 | Sell |
Chaikin Money Flow: | -698860 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.94 - 28.06) | Sell |
Bollinger Bands (100): | (25.84 - 30.6) | Sell |
NAVB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.67 | Sell |
Chaikin Money Flow: | -16832 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.04 - 0.04) | Sell |
Bollinger Bands (100): | (0.04 - 0.06) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.8 | Sell |
20-day SMA: | 26.03 | Sell |
50-day SMA: | 27.55 | Sell |
200-day SMA: | 31.53 | Sell |
8-day EMA: | 24.7 | Sell |
20-day EMA: | 25.86 | Sell |
50-day EMA: | 27.05 | Sell |
200-day EMA: | 31.51 | Sell |
NAVB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.04 | Sell |
20-day SMA: | 0.04 | Sell |
50-day SMA: | 0.04 | Sell |
200-day SMA: | 0.06 | Sell |
8-day EMA: | 0.04 | Sell |
20-day EMA: | 0.04 | Sell |
50-day EMA: | 0.04 | Sell |
200-day EMA: | 0.09 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.
Navidea Biopharmaceuticals Earnings Growth & NAVB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intellia Therapeutics Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Navidea Biopharmaceuticals Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |